FDA Clears GE HealthCare’s MIM LesionID Pro for Automated Tumor Burden Analysis
The AI-enabled software automates whole-body tumor burden analysis for PSMA PET/CT and SPECT/CT studies to help clinicians assess treatment eligibility and monitor response.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
